Article Text

PDF
Coronary heart disease in China
  1. X-H Zhang1,
  2. Z L Lu2,
  3. L Liu3
  1. 1
    Department of Community and Family Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
  2. 2
    Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
  3. 3
    National CVD Centre, Ministry of Health, PRC And Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
  1. Professor X-H Zhang, Department of Community and Family Medicine, School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong; zhangxh{at}cuhk.edu.hk

Abstract

Coronary heart disease (CHD) is the second leading cause of cardiovascular death in the Chinese population. It accounts for 22% of cardiovascular deaths in urban areas and 13% in rural areas. Although mortality from CHD in China is relatively low compared with Western levels, the burden of CHD has been increasing. This is partly because of a worsening profile of risk factors, such as an increased prevalence of hypertension, hyperlipidaemia, overweight/obesity, diabetes, etc and partly because of an increase in the aged population. Large-scale, randomised controlled trials on thrombolytic, blood-pressure-lowering, antiplatelet and blood-cholesterol-lowering treatment as well as cardiac intervention have been conducted for Chinese patients with myocardial infarction. The studies provide important information for the prevention and management of chronic CHD and acute myocardial infarction in the Chinese population.

Statistics from Altmetric.com

Footnotes

  • None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.